Knowledge Gaps in Placenta Accreta Spectrum

Daniela A. Carusi; Christina M. Duzyj; Jonathan L. Hecht; Alexander J. Butwick; Jon Barrett; Roxane Holt; Susan E. O'Rinn; Yalda Afshar; Jennifer B. Gilner; J. M. Newton; Scott A. Shainker; for the Pan-American Society for the Placenta Accreta Spectrum

doi:10.1055/s-0043-1761635

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2023; 40(09): 962-969
DOI: 10.1055/s-0043-1761635

PAS Series Article

Clinical Opinion

Knowledge Gaps in Placenta Accreta Spectrum

Daniela A. Carusi

¹Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

,

Christina M. Duzyj

²Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

,

Jonathan L. Hecht

³Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

,

Alexander J. Butwick

⁴Department of Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Stanford, California

,

Jon Barrett

⁵Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada

,

Roxane Holt

⁶Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois

,

Susan E. O'Rinn

⁷Sunnybrook Research Institute, Toronto, Ontario, Canada

,

Yalda Afshar

⁸Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California

,

Jennifer B. Gilner

⁹Division of Maternal-Fetal Medicine, Duke University Medical Center, Durham, North Carolina

,

J. M. Newton

¹⁰Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee

,

Scott A. Shainker

¹¹Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

,

for the Pan-American Society for the Placenta Accreta Spectrum

› Institutsangaben

Abstract

Since its first description early in the 20th Century, placenta accreta and its variants have changed substantially in incidence, risk factor profile, clinical presentation, diagnosis and management. While systematic use of diagnostic tools and a multidisciplinary team care approach has begun to improve patient outcomes, the condition's pathophysiology, epidemiology, and best practices for diagnosis and management remain poorly understood. The use of large databases with broadly accepted terminology and diagnostic criteria should accelerate research in this area. Future work should focus on non-traditional phenotypes, such as those without placenta previa–preventive strategies, and long term medical and emotional support for patients facing this diagnosis.

Key Points

Placenta accreta spectrum research may be improved with standardized terminology and use of large databases.
Placenta accreta prediction should move beyond ultrasound with the addition of biomarkers, and needs to extend to those without traditional risk factors.
Future research should identify practices that can prevent future accreta development.

Keywords

placenta accreta spectrum - pathophysiology - prevention - patient management

Volltext

Referenzen

References
1 Irving FC, Hertig AT. A study of placenta accreta. Am J Obstet Gynecol 1937; 38 (06) 1088-1200
2 Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009; 116 (05) 648-654
3 Warshak CR, Ramos GA, Eskander R. et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010; 115 (01) 65-69
4 Silver RM, Landon MB, Rouse DJ. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107 (06) 1226-1232
5 Bailit JL, Grobman WA, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015; 125 (03) 683-689
6 American College of Obstetricians and Gynecologists. Obstetric care consensus no. 7 summary: placenta accreta spectrum. Obstet Gynecol 2018; 132 (06) 1519-1521
7 Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med 2018; 378 (16) 1529-1536
8 Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005; 192 (05) 1458-1461
9 Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985; 66 (01) 89-92
10 Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997; 177 (01) 210-214
11 Usta IM, Hobeika EM, Musa AAA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol 2005; 193 (3, pt 2): 1045-1049
12 Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980; 56 (01) 31-34
13 Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 2013; 208 (03) 219.e1-219.e7
14 Thurn L, Lindqvist PG, Jakobsson M. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016; 123 (08) 1348-1355
15 Hobson SR, Kingdom JC, Murji A. et al. No. 383-screening, diagnosis, and management of placenta accreta spectrum disorders. J Obstet Gynaecol Can 2019; 41 (07) 1035-1049
16 Jauniaux E, Alfirevic Z, Bhide AG. et al; Royal College of Obstetricians and Gynaecologists. Placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a. BJOG 2019; 126 (01) e1-e48
17 Kaser DJ, Melamed A, Bormann CL. et al. Cryopreserved embryo transfer is an independent risk factor for placenta accreta. Fertil Steril 2015; 103 (05) 1176-84.e2
18 Modest AM, Toth TL, Johnson KM, Shainker SA. Placenta accreta spectrum: in vitro fertilization and non-in vitro fertilization and placenta accreta spectrum in a Massachusetts cohort. Am J Perinatol 2021; 38 (14) 1533-1539
19 Salmanian B, Fox KA, Arian SE. et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol 2020; 223 (04) 568.e1-568.e5
20 Vermey BG, Buchanan A, Chambers GM. et al. Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis. BJOG 2019; 126 (02) 209-218
21 Baldwin HJ, Patterson JA, Nippita TA. et al. Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet Gynecol 2018; 131 (02) 227-233
22 Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012; 7 (12) e52893
23 Shainker SA, Silver RM, Modest AM. et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol 2020; 223 (03) 433.e1-433.e14
24 Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet 2018; 140 (03) 291-298
25 Fox KA, Shamshirsaz AA, Carusi D. et al. Conservative management of morbidly adherent placenta: expert review. Am J Obstet Gynecol 2015; 213 (06) 755-760
26 Dannheim K, Shainker SA, Hecht JL. Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. Arch Gynecol Obstet 2016; 293 (05) 951-958
27 Duzyj CM, Buhimschi IA, Laky CA. et al. Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study. BJOG 2018; 125 (11) 1441-1448
28 Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218 (01) 75-87
29 Duzyj CM, Cooper A, Mhatre M. et al. Placenta accreta: a spectrum of predictable risk, diagnosis, and morbidity. Am J Perinatol 2019; 36 (10) 1031-1038
30 Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 2008; 29 (07) 639-645
31 Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A. Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion. Obstet Gynecol 2020; 135 (05) 1104-1111
32 Hannon T, Innes BA, Lash GE, Bulmer JN, Robson SC. Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta - an immunohistochemical study. Placenta 2012; 33 (12) 998-1004
33 Wehrum MJ, Buhimschi IA, Salafia C. et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol 2011; 204 (05) 411.e1-411.e11
34 DaSilva-Arnold SC, Zamudio S, Al-Khan A. et al. Human trophoblast epithelial-mesenchymal transition in abnormally invasive placenta. Biol Reprod 2018; 99 (02) 409-421
35 Hecht JL, Karumanchi SA, Shainker SA. Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders. Arch Gynecol Obstet 2020; 301 (02) 499-507
36 Ben-Nagi J, Walker A, Jurkovic D, Yazbek J, Aplin JD. Effect of cesarean delivery on the endometrium. Int J Gynaecol Obstet 2009; 106 (01) 30-34
37 Randall S, Buckley CH, Fox H. Placentation in the fallopian tube. Int J Gynecol Pathol 1987; 6 (02) 132-139
38 Shainker SA, Dannheim K, Gerson KD. et al. Down-regulation of soluble fms-like tyrosine kinase 1 expression in invasive placentation. Arch Gynecol Obstet 2017; 296 (02) 257-262
39 McMahon K, Karumanchi SA, Stillman IE, Cummings P, Patton D, Easterling T. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta. Am J Obstet Gynecol 2014; 210 (01) 68.e1-68.e4
40 Duzyj CM, Buhimschi IA, Motawea H. et al. The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin. Placenta 2015; 36 (06) 645-651
41 Esh-Broder E, Ariel I, Abas-Bashir N, Bdolah Y, Celnikier DH. Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG 2011; 118 (09) 1084-1089
42 Borem P, de Cássia Sanchez R, Torres J. et al. A quality improvement initiative to increase the frequency of vaginal delivery in Brazilian hospitals. Obstet Gynecol 2020; 135 (02) 415-425
43 Gyamfi-Bannerman C, Gilbert S, Landon MB. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment. Obstet Gynecol 2012; 120 (06) 1332-1337
44 Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol 2014; 31 (09) 799-804
45 Kaelin Agten A, Cali G, Monteagudo A, Oviedo J, Ramos J, Timor-Tritsch I. The clinical outcome of cesarean scar pregnancies implanted “on the scar” versus “in the niche”. Am J Obstet Gynecol 2017; 216 (05) 510.e1-510.e6
46 Sholapurkar SL. Increased incidence of placenta praevia and accreta with previous caesareans–a hypothesis for causation. J Obstet Gynaecol 2013; 33 (08) 806-809
47 Sumigama S, Sugiyama C, Kotani T. et al. Uterine sutures at prior caesarean section and placenta accreta in subsequent pregnancy: a case-control study. BJOG 2014; 121 (07) 866-874 , discussion 875
48 Abalos E, Addo V, Brocklehurst P. et al; CORONIS collaborative group. Caesarean section surgical techniques: 3 year follow-up of the CORONIS fractional, factorial, unmasked, randomised controlled trial. Lancet 2016; 388 (10039): 62-72
49 Carusi DA, Fox KA, Lyell DJ. et al. Placenta accreta spectrum without placenta previa. Obstet Gynecol 2020; 136 (03) 458-465
50 Silver RM, Fox KA, Barton JR. et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2015; 212 (05) 561-568
51 Wright JD, Herzog TJ, Shah M. et al. Regionalization of care for obstetric hemorrhage and its effect on maternal mortality. Obstet Gynecol 2010; 115 (06) 1194-1200
52 Eller AG, Bennett MA, Sharshiner M. et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011; 117 (2 Pt 1): 331-337
53 Shamshirsaz AA, Fox KA, Salmanian B. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212 (02) 218.e1-218.e9
54 Nguyen-Lu N, Carvalho JCA, Kingdom J, Windrim R, Allen L, Balki M. Mode of anesthesia and clinical outcomes of patients undergoing cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. Can J Anaesth 2016; 63 (11) 1233-1244
55 Markley JC, Farber MK, Perlman NC, Carusi DA. Neuraxial anesthesia during cesarean delivery for placenta previa with suspected morbidly adherent placenta: a retrospective analysis. Anesth Analg 2018; 127 (04) 930-938
56 Taylor NJ, Russell R. Anaesthesia for abnormally invasive placenta: a single-institution case series. Int J Obstet Anesth 2017; 30: 10-15
57 Sentilhes L, Ambroselli C, Kayem G. et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010; 115 (03) 526-534
58 Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol 2010; 202 (01) 38.e1-38.e9
59 Salim R, Chulski A, Romano S, Garmi G, Rudin M, Shalev E. Precesarean prophylactic balloon catheters for suspected placenta accreta: a randomized controlled trial. Obstet Gynecol 2015; 126 (05) 1022-1028
60 Pan Y, Zhou X, Yang Z, Cui S, De W, Sun L. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. Int J Gynaecol Obstet 2017; 137 (01) 45-50
61 Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J. Transfusion requirements in obstetric patients with placenta accreta. Transfusion 2011; 51 (12) 2627-2633
62 Wright JD, Pri-Paz S, Herzog TJ. et al. Predictors of massive blood loss in women with placenta accreta. Am J Obstet Gynecol 2011; 205 (01) 38.e1-38.e6
63 Brookfield KF, Goodnough LT, Lyell DJ, Butwick AJ. Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion 2014; 54 (06) 1530-1536
64 Panigrahi AK, Yeaton-Massey A, Bakhtary S. et al. A standardized approach for transfusion medicine support in patients with morbidly adherent placenta. Anesth Analg 2017; 125 (02) 603-608
65 US National Library of Medicine Website. Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study (TAPPAS). Accessed August 5, 2020, at: https://clinicaltrials.gov/ct2/show/NCT02806024
66 Shamshirsaz AA, Fox KA, Erfani H. et al. Coagulopathy in surgical management of placenta accreta spectrum. Eur J Obstet Gynecol Reprod Biol 2019; 237: 126-130
67 Tol ID, Yousif M, Collins SL. Post traumatic stress disorder (PTSD): the psychological sequelae of abnormally invasive placenta (AIP). Placenta 2019; 81: 42-45
68 Carroll M, Daly D, Begley CM. The prevalence of women's emotional and physical health problems following a postpartum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2016; 16 (01) 261
69 Delicate A, Ayers S, Easter A, McMullen S. The impact of childbirth-related post-traumatic stress on a couple's relationship: a systematic review and meta-synthesis. J Reprod Infant Psychol 2018; 36 (01) 102-115
70 Sentilhes L, Gromez A, Clavier E, Resch B, Descamps P, Marpeau L. Long-term psychological impact of severe postpartum hemorrhage. Acta Obstet Gynecol Scand 2011; 90 (06) 615-620
71 de la Cruz CZ, Coulter M, O'Rourke K, Mbah AK, Salihu HM. Post-traumatic stress disorder following emergency peripartum hysterectomy. Arch Gynecol Obstet 2016; 294 (04) 681-688
72 Scott SD, Hirschinger LE, Cox KR, McCoig M, Brandt J, Hall LW. The natural history of recovery for the healthcare provider “second victim” after adverse patient events. Qual Saf Health Care 2009; 18 (05) 325-330